Ulcerative colitis

This page contains changes which are not marked for translation.


Background

Average inner diameters and ranges of different sections of the large intestine.[1]
  • Inflammation tends to be progressively more severe from proximal to distal colon
  • Rectum is almost always involved
  • Peak incidence occurs in second and third decades of life

Crohn's disease vs. ulcerative colitis

Finding Crohn's disease Ulcerative colitis
Depth of inflammation May be transmural, deep into tissues Shallow, mucosal
Distribution of disease Patchy areas of inflammation (skip lesions) Continuous area of inflammation
Terminal ileum involvement Commonly Seldom
Colon involvement Usually Always
Rectum involvement Seldom Usually (95%)
Involvement around anus Common Seldom
Stenosis Common Seldom


Clinical Features


Classification

  • Mild
    • <4 bowel movements per day
    • No systemic symptoms
    • Few extraintestinal manifestations
    • Occasional constipation and rectal bleeding
  • Moderate
  • Severe


Differential Diagnosis

Colitis


Evaluation

Work-up

  • CBC
  • Chemistry
  • LFTs/lipase
  • Consider:
    • ESR/CRP
    • Fecal calprotectin[2] (typically requested by GI)
    • Type and screen (if significant bleeding)
  • Imaging
    • Consider CT based on clinical features and need to rule out more concerning processes


Diagnosis

  • Positive atypical p-ANCA and negative ASCA is specific for ulcerative colitis


Management

  1. Rule-out complications:
  2. Steroids
    • Parenteral vs PO depending on severity
      • PO: prednisone 40mg x 2wks, then decrease by 5mg per week


Disposition

  • Admit for severe complication or severe flare requiring IV steroids


See Also


References

  1. Nguyen H, Loustaunau C, Facista A, Ramsey L, Hassounah N, Taylor H, et al. (July 2010). "Deficient Pms2, ERCC1, Ku86, CcOI in field defects during progression to colon cancer". Journal of Visualized Experiments (41). doi:10.3791/1931. PMC 3149991. PMID 20689513.
  2. van Rheenen PF, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ. 2010;15(341):c3369.